| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/29/2011 | US8067014 Chimeric AAV capsid proteins |
| 11/29/2011 | US8067013 Multivalent avian influenza vaccines |
| 11/29/2011 | US8067012 Treatment of melanoma using HSV mutant |
| 11/29/2011 | US8067011 Compositions and methods for treating B-cell malignancies |
| 11/29/2011 | US8067010 Immunological herpes simplex virus antigens and methods for use thereof |
| 11/29/2011 | US8067009 Metalloproteinase oligopeptides and their therapeutic use |
| 11/29/2011 | US8067008 Peptide inhibitors for mediating stress responses |
| 11/29/2011 | US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 11/29/2011 | US8067006 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| 11/29/2011 | US8067005 Divalent antibody fragments |
| 11/29/2011 | US8067004 Surface antigen |
| 11/29/2011 | US8067003 Methods of treating conditions using anti-IL-6 antibodies |
| 11/29/2011 | US8067002 Humanized anti-factor D antibodies |
| 11/29/2011 | US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 11/29/2011 | US8067000 Cancer treatment with endothelin receptor antagonists |
| 11/29/2011 | US8066999 PEGylated Aβ fab |
| 11/29/2011 | US8066998 Antibodies for norovirus |
| 11/29/2011 | US8066997 Modulation of activity of neurotrophins |
| 11/29/2011 | US8066996 Anti-CCR7 receptor antibodies for the treatment of cancer |
| 11/29/2011 | US8066995 Anti-myostatin antibodies |
| 11/29/2011 | US8066993 Use of ventricular enlargement rate in intravenous immunoglobulin treatment of Alzheimer's disease |
| 11/29/2011 | US8066992 Medicament and a method of treating a pathological syndrome |
| 11/29/2011 | US8066989 Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy |
| 11/29/2011 | US8066985 Reovirus for the treatment of cellular proliferative disorders |
| 11/29/2011 | US8066983 Attenuated poliovirus |
| 11/29/2011 | CA2624935C Anti-myostatin antibodies |
| 11/29/2011 | CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa |
| 11/29/2011 | CA2478645C Treatment of central nervous system damage |
| 11/29/2011 | CA2448208C Influenza vaccine composition |
| 11/29/2011 | CA2442909C Multimerization of hiv-1 vif protein as a therapeutic target |
| 11/29/2011 | CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 11/29/2011 | CA2423227C Reduced-viscosity concentrated protein formulations |
| 11/29/2011 | CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 11/29/2011 | CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 11/29/2011 | CA2366541C Novel recombinant and mutant herpesviruses |
| 11/29/2011 | CA2346931C Gene delivery system and methods of use |
| 11/29/2011 | CA2235224C Diagnostics and treatments of periodontal disease |
| 11/29/2011 | CA2233447C Mimicking peptides in cancer therapy |
| 11/24/2011 | WO2011146891A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins |
| 11/24/2011 | WO2011146727A1 Methods of treating interstitial cystitis |
| 11/24/2011 | WO2011146568A1 Predicting response to a her inhibitor |
| 11/24/2011 | WO2011146559A1 Combination therapy with ae37 peptide and an antibody that binds to her2/neu protein |
| 11/24/2011 | WO2011146395A2 Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade |
| 11/24/2011 | WO2011146382A1 Improved immunotherapeutic dosing regimens and combinations thereof |
| 11/24/2011 | WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo |
| 11/24/2011 | WO2011145723A1 Method for prevention or treatment of metabolic syndrome |
| 11/24/2011 | WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 11/24/2011 | WO2011145108A2 Purification of capsular polysaccharides |
| 11/24/2011 | WO2011145081A1 Influenza virus reassortment method |
| 11/24/2011 | WO2011145013A1 Parapoxvirus vectors containing rabies virus antigen |
| 11/24/2011 | WO2011144951A1 Mycobacterial antigen composition |
| 11/24/2011 | WO2011144818A1 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions |
| 11/24/2011 | WO2011144749A1 Biological materials related to her3 |
| 11/24/2011 | WO2011144360A1 Marker vaccine for classical swine fever |
| 11/24/2011 | WO2011143706A1 Methods relating to an attenuated mycoplasma |
| 11/24/2011 | WO2011123819A3 Epha3 antibodies for the treatment of multiple myeloma |
| 11/24/2011 | WO2011121305A3 Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| 11/24/2011 | WO2011120135A8 Antibodies with enhanced or suppressed effector function |
| 11/24/2011 | WO2011120134A8 Antibodies with enhanced or suppressed effector function |
| 11/24/2011 | WO2011113618A4 Immune therapy |
| 11/24/2011 | WO2011110683A3 Glce as a target for anti-tumour therapy |
| 11/24/2011 | WO2011110671A3 Pharmaceutical composition for the treatment of chlamydial infection |
| 11/24/2011 | WO2011109400A3 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 11/24/2011 | WO2011101634A3 Methods of prevention or treatment of triggered inflammatory reactions using tumor necrosis factor alpha antagonist |
| 11/24/2011 | WO2011092715A3 Method for in-vivo binding of chromatin fragments |
| 11/24/2011 | WO2011090266A3 Novel tumor antigen protein agr2 and tumor antigenic peptide thereof |
| 11/24/2011 | WO2011082422A3 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications |
| 11/24/2011 | WO2011075516A3 Active scaffolds for on-demand drug and cell delivery |
| 11/24/2011 | WO2011062786A3 Compounds and methods for inhibiting the metastasis of cancer cells |
| 11/24/2011 | WO2011060431A3 Multivalent live vector vaccine against clostridium difficile-associated disease |
| 11/24/2011 | WO2011056056A3 Anti-cytokine vhnar domains |
| 11/24/2011 | WO2010129469A8 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies |
| 11/24/2011 | WO2010128524A8 Combined measles-malaria vaccine |
| 11/24/2011 | US20110289606 Equine disease model for herpesvirus neurologic disease and uses thereof |
| 11/24/2011 | US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease |
| 11/24/2011 | US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof |
| 11/24/2011 | US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/24/2011 | US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT |
| 11/24/2011 | US20110287410 Hepatitis-c virus testing |
| 11/24/2011 | US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 11/24/2011 | US20110287088 Modulation of olfml-3 mediated angiogenesis |
| 11/24/2011 | US20110287087 Modified cationic liposome adjuvans |
| 11/24/2011 | US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
| 11/24/2011 | US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line |
| 11/24/2011 | US20110287057 Cancer Treatment |
| 11/24/2011 | US20110287055 Compositions comprising prfa* mutant listeria and mehtods of use thereof |
| 11/24/2011 | US20110287054 Multivalent adjuvanted influenza virus compositions |
| 11/24/2011 | US20110287053 Recombinant Foot and Mouth Disease Vaccine |
| 11/24/2011 | US20110287052 Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
| 11/24/2011 | US20110287051 Parapoxvirus vectors |
| 11/24/2011 | US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
| 11/24/2011 | US20110287047 Cross-beta structures as carrier in vaccines |
| 11/24/2011 | US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides |
| 11/24/2011 | US20110287045 Enhanced immune response against infections |
| 11/24/2011 | US20110287044 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv |
| 11/24/2011 | US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/24/2011 | US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same |
| 11/24/2011 | US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification |